In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).